Thickened carotid artery intima-media in rheumatoid arthritis is associated with elevated anticardiolipin antibodies

Abstract

Antiphospholipid and anti-oxidized LDL (anti-oxLDL) antibodies are associated with thrombosis and atherosclerosis. Rheumatoid arthritis (RA) is characterized by excess atherosclerosis and cardiovascular diseases. Our aim was to determine whether antiphospholipid and anti-oxLDL antibodies are associated with early atherosclerotic changes in RA. The levels of IgG and IgM anticardiolipin, IgG and IgM anti-beta-2-glycoprotein-I and anti-oxLDL autoantibodies have been evaluated in 82 patients having RA. Carotid artery intima-media thickness (IMT) was measured in the carotid arteries in the common carotid, bifurcation and internal carotid arteries. Elevated levels of IgG anticardiolipin antibodies were detected in 17 of 82 (21%) RA patients, including 7 with medium-to-high levels considered being clinically relevant. These patients had significantly elevated mean carotid and carotid bifurcation IMT compared with RA patients without elevated anticardiolipin. No such association was found regarding other autoantibodies tested. Anticardiolipin antibodies are prevalent in RA and are associated with early atherosclerotic changes, supporting a rational for measuring them in RA, and upon detection treat the patients in order to decrease chances of atherosclerosis progression and thrombosis. Lupus (2007) 16, 259—264.

Keywords

anticardiolipin antiphospholipid antibody intima-media thickness rheumatoid arthritis

Get full access to this article

View all access options for this article.

References

Shoenfeld Y. , Gerli R. , Doria A. , Matsuura E. , Matucci Cerinic M , Ronda N. , Jara LJ , Abu-Shakra M. , Meroni PL , Sherer Y. Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation 2005; 112: 3337—3347.

Shoenfeld Y. , Sherer Y. , Harats D. Atherosclerosis as an infectious, inflammatory and autoimmune disease. Trends Immunol 2001 ; 22: 293—295.

Sherer Y. , Shoenfeld Y.

Mechanisms of disease: atherosclerosis in autoimmune diseases. Nat Clin Prac

Rheumatol 2006; 2: 99—106.

Sherer Y. , Gerli R. , Vaudo G. , Schillaci G. , Gilburd B. , Giordano A. , Bocci EB , Allegrucci R. , Marchesi S. , Mannarino E. , Shoenfeld Y. Prevalence of antiphospholipid and anti-oxidized low-density lipoprotein antibodies in rheumatoid arthritis. Ann N Y Acad Sci 2005; 1051: 299—303.

Amett FC , Edworthy SM , Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315—324.

Vaudo G. , Schillaci G. , Evangelista F. et al. Arterial wall thickening at different sites and its association with left ventricular hypertrophy in newly diagnosed essential hypertension . Am J Hypertens 2000; 13: 324—331.

Miyakis S. , Lockshin MD , Atsumi T. et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295—306.

Rodriguez G. , Sulli A. , Cutolo M. , Vitali P. , Nobili F. Carotid atherosclerosis in patients with rheumatoid arthritis: a preliminary case-control study. Ann N Y Acad Sci 2002; 966: 478—482.

Jonsson SW , Backman C. , Johnson O. et al. Increased prevalence of atherosclerosis in patients with medium term rheumatoid arthritis. J Rheumatol 2001 ; 28: 2597—2602.

10.

Kumeda Y. , Inaba M. , Goto H. et al. Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis. Arthritis Rheum 2002; 46: 1489—1497.

11.

Park YB , Ahn CW , Choi HK et al. Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound. Arthritis Rheum 2002 ; 46: 1714—1719.

12.

Alkaabi JK , Ho M. , Levison R. et al. Rheumatoid arthritis and macrovascular disease. Rheumatology 2003; 42: 292—297.

13.

Del Rincon I. , Williams K. , Stern MP et al. Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects . Arthritis Rheum 2003; 48: 1833—1840.

14.

Grover S. , Sinha RP , Singh U. , Tewari S. , Aggarwal A. , Misra R. Subclinical atherosclerosis in rheumatoid arthritis in India. J Rheumatol 2006; 33: 201—203.

15.

del Rincon I. , Freeman GL , Haas RW , O'Leary DH , Escalante A. Relative contribution of cardiovascular risk factors and rheumatoid arthritis clinical manifestations to atherosclerosis . Arthritis Rheum 2005; 52: 3413—3423.

16.

Wada Y. , Kuroda T. , Murasawa A. , Tanabe N. , Nakano M. , Gejyo F. Autoantibodies against oxidized low-density lipoprotein (LDL) and carotid atherosclerosis in patients with rheumatoid arthritis. Clin Exp Rheumatol 2005; 23: 482—486.

17.

Abu-Shakra M. , Polychuck I. , Szendro G. , Bolotin A. , Jonathan BS , Flusser D. , Buskila D. , Sukenik S. Duplex study of the carotid and femoral arteries of patients with rheumatoid arthritis: a controlled study. Semin Arthritis Rheum 2005; 35: 18—23.

18.

Gonzalez-Gay MA , Gonzalez-Juanatey C. , Pineiro A. , Garcia-Porrua C. , Testa A. , Llorca J. High-grade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis. J Rheumatol 2005; 32: 1219—1223.

19.

Wallberg-Jonsson S. , Ohman M. , Rantapaa-Dahlqvist S.

Which factors are related to the presence of atherosclerosis in rheumatoid arthritis?

Scand J Rheumatol 2004; 33: 373—379.

20.

Dessein PH , Joffe BI , Veller MG , Stevens BA , Tobias M. , Reddi K. , Stanwix AE Traditional and nontraditional cardiovascular risk factors are associated with atherosclerosis in rheumatoid arthritis. J Rheumatol 2005; 32: 435—442.

21.

Gerli R. , Schillaci G. , Giordano A. , Bocci EB , Bistoni O. , Vaudo G. , Marchesi S. , Pirro M. , Ragni F. , Shoenfeld Y. , Mannarino E. CD4+CD28- T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients. Circulation 2004; 109: 2744—2748.

22.

Gonzalez-Juanatey C. , Llorca J. , Testa A. , Revuelta J. , Garcia-Porrua C. , Gonzalez-Gay MA Increased prevalence of severe subclinical atherosclerotic findings in long-term treated rheumatoid arthritis patients without clinically evident atherosclerotic disease. Medicine 2003; 82: 407—413.

23.

Nagata-Sakurai M. , Inaba M. , Goto H. , Kumeda Y. , Furumitsu Y. , Inui K. , Koyama H. , Emoto M. , Ishimura E. , Shoji T. , Nishizawa Y. Inflammation and bone resorption as independent factors of accelerated arterial wall thickening in patients with rheumatoid arthritis. Arthritis Rheum 2003; 48: 3061—3067.

24.

Gerli R. , Sherer Y. , Vaudo G. et al. Early atherosclerosis in rheumatoid arthritis: effects of smoking on thickness of the carotid artery intima media. Ann N Y Acad Sci 2005; 1051: 281—290.

25.

Elkayam O. , Burke M. , Vardinon N. , Zakut V. , Yitzhak RB , Paran D. , Levartovsky D. , Litinsky I. , Caspi D. Autoantibodies profile of rheumatoid arthritis patients during treatment with infliximab. Autoimmunity 2005; 38: 155—160.

26.

Olech E. , Merrill JT The prevalence and clinical significance of antiphospholipid antibodies in rheumatoid arthritis. Curr Rheumatol Rep 2006 ; 8: 100—108.

27.

George J. , Afek A. , Gilburd B. et al. Atherosclerosis in LDL-receptor knockout mice is accelerated by immunization with anticardiolipin antibodies. Lupus 1997; 6: 723.

28.

Vaarala O. , Manttari M. , Manninen V. et al. Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men. Circulation 1995; 91: 23.

29.

Sherer Y. , Shemesh J. , Tenenbaum A. et al. Coronary calcium and anticardiolipin antibody are elevated in patients with typical chest pain. Am J Cardiol 2000; 86: 1306.